The process of germline development carries genetic information and preparatory totipotency across generations. The last decade has witnessed remarkable successes in the generation of germline cells from mouse pluripotent stem cells, especially induced germline cells with the capacity for producing viable offspring, suggesting clinical applications of induced germline cells in humans. However, to date, the culture systems for germline induction with accurate sex-specific meiosis and epigenetic reprogramming have not been well-established. In this study, we primarily focus on the mouse model to discuss key signaling events for germline induction. We review mechanisms of competent regulators on primordial germ cell induction and discuss current achievements and difficulties in inducing sexspecific germline development. Furthermore, we review the developmental identities of mouse embryonic stem cells and epiblast stem cells under certain defined culture conditions as it relates to the differentiation process of becoming germline cells.
INTRODUCTION
During the mouse life cycle, genetic information is carried through a pluripotent state between two rounds of epigenetic reprogramming events in primordial germ cells (PGCs) and early zygotic development [1] . In mice, PGC precursors are established from the most proximal epiblast cells before the appearance of the three germ layers [2] . During the developmental process of pluripotent epiblast cells progressing toward PGCs, PGCs inherit a number of pluripotency genes from pluripotent cells and reignite a number of pluripotency genes that are transitorily lost in PGC precursors [3] . Even so, PGCs are restricted to a unipotent lineage that only generates gametes. In vitro, mutual conversions of the PGC-like state and the pluripotent state can be easily achieved using various methods. PGCs can be reversed into pluripotent embryonic germ cells (EGCs) using an in vitro culture system [4, 5] . Mouse embryonic stem cells (ESCs) undergoing an epiblastlike cell (EpiLC) state transition can generate PGC-like cells (PGCLCs) with transcriptional and epigenetic profiles similar to migrating PGCs, and these PGCLCs can undergo normal gametogenesis in recipient mice [6] [7] [8] . Several key signaling pathways involved in directing EpiLCs into the PGCLC state have been identified; these include exogenous cytokines containing BMP4 and simultaneous overexpression of Prdm1, Prdm14, and Tfap2c [6] [7] [8] . Induced germline cells subjected to certain culture conditions can enter into meiosis and generate gametes [9] [10] [11] . Of note, retinoic acid-induced mouse spermlike cells produce mouse offspring, although they die prematurely and show improper methylation imprints [10] . The precise signaling for gamete maturation needs to be elucidated. In this study, we provide an overview of key signaling events involved in mouse germline induction, aiming to elucidate the mechanism of mouse germline development and to provide a reference on how to obtain induced mature human gametes with the aim of clinical applications of infertility.
GERMLINE SPECIFICATION
PRDM1 and PRDM14 as Guides to Determine PGC Development PRDM1 and PRDM14 are two PR domain-containing (PRDM), ZFN-domain transcriptional regulators that are essential for the establishment of PGCs. At Embryonic Day (E) 6.25, PRDM1 activation in the most proximal epiblast cells has been identified as the initiating marker of lineage-restricted PGC precursors that is activated quantitatively by BMP4 [2, 12] . At E6.5, PRDM14 is also induced by BMP4 [13] . However, the initial activation of PRDM14 appears to be independent of PRDM1 because the early expression of PRDM14 is fairly normal in prdm1 À/À embryos [13] . The key functions of PRDM1 and PRDM14 during PGC development can be analyzed from their mutant embryo phenotypes. At the early bud stage (EB, ;E7.25), a cluster of approximately 40 founder PGCs is identifiable with the expression of ALPL and DPPA3 at the bottom of the incipient allantois [2] . In the prdm1 À/À embryos, only an average of 6.5 DPPA3-positive cells are observed at the EB stage [2] . Compared with wild embryos, the DPPA3-positive mutant cells in prdm1 À/À embryos show inconsistent repression of somatic homeobox (Hox) genes and inconsistent reacquisition of transcription for the pluripotency genes Sox2 and Nanos3 [2] . At the late bud stage (;E7.5), the ALPL-positive cells (defective PGCs) in the prdm1 À/À embryos fail to proliferate and remain as a tight cluster with few migrating cells [2] . At around E9.0-9.5, there are no alkaline phosphatase (AP)-positive PGCs, and no migrating PGCs are observed within the hindgut in prdm1 À/À embryos [14] . The prdm14 À/À embryos show decreased numbers of PRDM1-positive cells as early as at the EB stage [13] . At the early to midbud stage, no significant difference in the Prdm1 transcription level in prdm14 À/À and wild PGCs is observed, but the level of Dppa3 transcription in prdm14
PGCs is about 4-fold less than that of wild PGCs [13] . Although the PGCs in prdm14 À/À embryos show proper transcription of pluripotency genes Pou5f1 and Nanog, the reacquisition of Sox2 transcription is severely impaired [13] . Of note, these cells can repress the somatic mesodermal genes Hoxa1, Hoxb1, and Snai1 [13] , suggesting that the process is controlled mainly through PRDM1. The repression of EHMT1, a histone methyltransferase that mediates histone H3 lysine 9 dimethylation (H3K9me2) in PGCs at approximately E7.75, is considered to be a marker of the beginning of the epigenetic reprogramming process. At E8.0, the PGCs in the prdm14 À/À embryos fail to repress EHMT1 properly, which in turn cannot downregulate H3K9me2 at E8.5 and upregulate histone H3 lysine 27 trimethylation (H3K27me3) at E9.5, demonstrating the key role of PRDM14 in triggering the epigenetic reprogramming in migrating PGCs [13] .
The PR domain is related to the SET methyltransferase domain, but no intrinsic enzymatic activities have been attributed to PRDM1 and PRDM14 [15] . They recruit various transcription factors to regulate diverse cell fates dependent on the cellular context [15] . In PGCs, PRDM1 associates with TFAP2c and SALL4 to repress the somatic mesodermal program, as evidenced by the fact that derepression of HOXA1 and HOXB1 occurs in tfap2c
À/À embryos [16, 17] . Furthermore, the PGCs in tfap2c À/À or sall4 À/À embryos fail to migrate into the endoderm [16, 17] , a phenotype that is a similar to that of PGCs in prdm1 À/À embryos. However, activation of the pluripotent genes is not impaired in sall4 À/À embryos [17] . One possibility could be that PRDM1 activates pluripotency genes with other transcription factors. Additionally, PRDM1 is essential for the maintenance of PRDM14 [3, 13] ; therefore, the impaired Sox2 transcription in prdm1 À/À embryos probably results from low levels of PRDM14, rather than the absence of PRDM1. In migrating PGCs, PRDM1 also functions in a complex with TFAP2C or PRMT5 to repress some pluripotency genes with a role in preventing the PGCs from acquiring a pluripotent stem cell-like phenotype [18, 19] . The tfap2c þ/À male mice develop testicular tumors that resembles embryonal carcinoma cells because PGCs fail to downregulate pluripotency genes [19] . Furthermore, TFAP2C can repress the cell cycle and DNA methylation during the migration of PGCs [19] .
TFAP2c expression is dependent on PRDM1 [3, 16] as deduced from the observation that Tfap2c transcription level is highly reduced in prdm1 À/À PGCs [3] . Although TFAP2c alone has a significant impact on gene expression, only genes cobound with additional PRDM1 and/or PRDM14 belong to the PGC specification categories in E7.5 PGCs [20] . PRDM1, PRDM14, and TFAP2c coexpress in PGCs up to about E12.5 when PGCs arrive in the genital ridge, and they form a mutually interdependent transcriptional network for PGC initiation, maintenance, and maturation ( Fig. 1 ) [20] . In summary, PRDM1 and PRDM14 are not only initiators for PGC specification but also act as dominant coordinators throughout PGC development.
Under conditions of floating aggregates in Glasgow minimum essential medium with 15% knockout serum replacement (GK15), ectopic expression of PRDM1, PRDM14, and TFAP2c (together as P1P14A) in Day 2 EpiLCs are sufficient for inducing the generation of PGCLCs [8] . The PGCLCs induction over 4 days show robust upregulation of key PGC development genes (Prdm1, Nanog, Nanos3, Pou5f1, Prdm14, Sox2, Dppa3, Tfap2c) and the downregulation of epigenetic modifier genes (Dnmt3a, Dnmt3b), but lacks the transient upregulation of somatic mesodermal genes, suggesting that P1P14A can directly activate the PGC program in EpiLCs. These P1P14A-induced PGCLCs undergo proper spermatogenesis in recipient mice upon germ cell transplantation, and the transplanted developmental spermatozoa generate healthy offspring by intracytoplasmic sperm injection. P1P14A-induced PGCLCs demonstrate that the epigenetic reprogramming during PGC migration is cellular-context dependent [8] .
BMP4/WNT3 Signaling Specifies PGCs
There are two strategies for committing to the PGC fate. In the germ plasm strategy, such as in Drosophila, the specification of PGCs occurs at the syncytial blastoderm by maternally inherited cytoplasmic factors (germ plasm) that are localized to the posterior of the oocyte during oogenesis. The germ plasm is necessary and sufficient for PGC formation and maintenance. Another strategy is bone morphogenetic protein (BMP) signal induction (Fig. 2) , which exists in mice and most likely in all the other mammals. Additionally, BMP4 signaling is involved in the generation of PGCs in Drosophila and also in other lower animals [21, 22] .
BMP4 and BMP8b from extraembryonic ectoderm (ExE) and BMP2 from visceral endoderm (VE) are the relevant BMPsignaling molecules, and mutation of these factors can result in no PGCs or greatly reduced numbers of PGCs [12, 23, 24] . 
WANG AND CAO
These molecules' respective function can be understood upon induction using explants (cultured embryos) in GK15 culture conditions [25] . BMP4 directly induces isolated E6.0 epiblast (with ExE and VE being removed) to generate PGCLCs that are PRDM1 and AP positive. BMP4 does not activate PRDM1 in the epiblast (Epi) with VE (ExE being removed) in the culture; however, the addition of BMP8b activates PRDM1. BMP8b regulates PGC specification by restricting the development of the anterior VE that secretes signals that inhibit PGC specification (e.g., CER1 against BMP4, DKK1a-gainst wingless-type MMTV integration site family [WNT] , and Lefty1 against Nodal) [25, 26] . BMP2 also induces PRDM1 and PRDM14 in the epiblast with lower efficiency than BMP4 [25] . The key role of BMP2 is to regulate the development of the hindgut and allantois [23] . Most of the PGCs in the bmp2 À/À embryos fail to migrate due to abnormal hindgut development [23] .
BMP4 acts on the epiblast by binding a type I and II receptor complex to phosphorylate SMAD1/5. Phosphorylated SMAD1/5 then dimerizes with SMAD4 and translocates to the nucleus to regulate the transcription of target genes [27] . The pathway is demonstrated by no PGCs or greatly reduced numbers of PGCs in smad1 À/À or smad5 À/À embryos [28, 29] , while SMAD8, another dimerization factor in the BMP4-signaling pathway, is not expressed in the embryo until E9.5 [30] . Among the putative type I receptors of BMP4, only BMPR1A is expressed in the epiblast [31] , whereas BMPR1B is not expressed in the embryo until E9.5 [32] . Thus, this suggests that BMPR1A is the receptor of BMP4. Furthermore, other studies demonstrate that ACVR1 is essential for PGC specification because PGCs are absent in acvr1 À/À embryos [33] . However, acvr1 À/À embryos fail to thrive before PGC formation [34, 35] , so the precise mechanism of ACVR1 on PGC specification needs further study. One of the roles of ACVR1 is the upregulation of Brachyury (T) via WNT3 signaling in the epiblast [34] . Brachyury is a classical mesodermal factor, but it is also essential for PGC specification. Before E7.5, ACVR1 expression is mainly in the VE during gastrulation [35] , and BMP8b generally uses ACVR1 as the type I receptor. Thus, BMP8b probably acts through ACVR1 in the VE to regulate WNT3 signaling in the epiblast for PGC specification.
Brachyury is a downstream target gene of the canonical WNT3-signaling pathway, and it is essential for both PGC specification and mesoderm differentiation. In T À/À embryos, although BMP4 directly induces PRDM1 expression in PGC precursors, it is limited with low levels of PRDM1.These PGC precursors fail to express PRDM14 in T À/À embryos, suggesting that T is indispensable for PRDM14 expression [36] . Brachyury plays a critical role in the upregulation of PRDM1 and PRDM14 by binding to their transcriptional regulatory elements upon BMP4 signaling [36] . In contrast, most embryos fail to express T and show little or no mesodermal differentiation in bmp4 À/À mutant embryos [37] . BMP4/WNT3 action on either PGC or mesoderm development depends on the initial cellular context. The most proximal epiblast cells receiving a higher level of BMP4 can activate Prdm1 and repress WNT-response genes without including T SIGNALING PATHWAYS REGULATING GERMLINE DEVELOPMENT [36] . On one hand, PRDM1 and PRDM14 are the dominant coordinators for PGC specification. On the other hand, PRDM1 and PRDM14 can recruit the mesodermal factor T to support the PGC program as a mode of escaping mesodermal differentiation. PRDM1 is widely expressed in epiblasts of wnt3 À/À embryos [38] , indicating that WNT signaling inhibits PGC specification in deeper proximal epiblast cells [38] . PRDM1 and PRDM14 are not expressed in deeper proximal epiblast cells probably due to prior promotion to somatic differentiation via WNT3 signaling.
BMP4 alone is sufficient for PGCLC induction under the GK15 conditions. LIF is conducive for promoting the maintenance/proliferation of the PGCLCs, and the effect is higher with additional cytokines (including KITL, BMP8b, and EGF) [6] . The cytokine-induced PGCLCs over 6 days are capable of highly upregulating PGC specification genes and significantly reacquire Sox2 and Nanog transcription. Consistent with the transient upregulation of somatic mesodermal genes during PGC specification in vivo, these PGCLCs show transient upregulation of the mesodermal genes Hoxa1 and Hoxb1 on Day 2. The mesodermal genes are highly repressed on Day 4 when DPPA3 is expressed. Transcription profiles of the PGCLCs at Day 6 appear close to E9.5 PGCs, and the epigenetic profiles are consistent with that of migrating PGCs. The cytokine-induced PGCLCs (male or female) also develop into normal gametes in recipient mice [6, 7] .
State in Which Cells Can Undergo Germline Specification: Clues from the In Vitro Environment and Cellular Context
Mouse ESCs are commonly derived from inner cell masses (ICMs) or epiblasts of preimplantation embryos. Mouse ESCs bear a naïve (ground) state, which have two activated X chromosomes in female and are able to contribute to chimeras with high efficiency when injected into preimplantation host embryos. Mouse epiblast stem cells (EpiSCs) are commonly obtained from the epiblasts of early postimplantation embryos at E5.5-6.5 and are also derivable from the ICM cells [39] . EpiSCs represent a primed state, which have an inactivated X chromosome in females, and while they have impaired capacity to contribute to chimeras, EpiSCs can readily form teratomas. ESCs and EpiSCs can survive with indefinite self-renewal capacity in the artificial milieu of cell culture. In serum-free 2i (inhibitors of MEK and GSK3B) conditions, the ESC expression profiles are similar to that of the E4.5 epiblast [40] . Mouse EpiSCs from E5.5-8.25 embryos that are cultured with mouse embryonic fibroblast feeders and FGF2 conditions exhibit gene expression characteristics similar to the ectoderm of the late-stage gastrula embryo [41] .
Under LIF and serum (or BMP4) conditions [42] , naïve pluripotent stem cells are readily available from the 129 mouse strain with chromosomes that harbor susceptibility genes for testicular germ cell tumors or less commonly from the C57BL/ 6 strain or hybrids thereof. Such ESCs consist of a heterogeneous marker population with the expression of some germline genes [43, 44] . During ICM outgrowth adaptation to LIF and serum conditions, some cells enter into a germlinelike state with the expression of PRDM1, PRDM14, and other genes typically associated with early germ cell specification [45] . PRDM1-positvie cells from Day 4 ICM outgrowths increase the efficiency of the generation of ESC lines by more than 9-fold [45] . However, the established ESC lines from prdm1 À/À and wild embryos show no obvious differences in the quantity and phenotype [45] . Furthermore, no ESC lines have been derived from prdm14 À/À ICMs in LIF/serum conditions [46] . [40, 46] . PRDM14 is only expressed in 2-to 8-cell blastomeres and in PGCs/PGC precursors to safeguard them from entering an extraembryonic developmental fate [12, 47] . ESCs utilize the PRDM14 signal for supporting pluripotency and inhibiting the extraembryonic endoderm fate [48, 49] .
Under Activin and FGF2 conditions, EpiSCs consist of a heterogeneous population with a spontaneous capacity for generating PGCs [50] . Additionally, some PGCs revert to the EpiSCs state in a dynamic equilibrium manner. The pluripotent PRDM1-negative EpiSCs first differentiate into PRDM1-positive PGC precursors and then express DPPA3 to become PGCs, resembling PGC specification in vivo. BMP4 concentration is the positive correlation factor for driving the EpiSC change to PGCs, but the proportion of the DPPA3-positive PGCs remains at low frequency (;1.5%), even in the presence of BMP4 (500 ng/ml). The PGCs derived from EpiSCs undergo appropriate transcriptional and epigenetic events. Further, such PGCs proliferate and develop further into oocytelike cells when cocultured with E12.5 female gonadal cells under EpiSC culture conditions, and they are able to dedifferentiate into pluripotent EGCs.
POU5F1 expression levels are similar in ESCs and EpiSCs [51] [52] [53] , though many pluripotency-associated transcription factors in ESCs are absent or present at low levels in EpiSCs [53, 54] . ESCs preferentially use the distal enhancer for the Pou5f1 gene transcription, whereas EpiSCs preferentially use the proximal enhancer [53] . Under Activin and FGF2 conditions, approximately 0.5% of EpiSCs express the Pou5f1 gene through both distal and proximal enhancers. Such cells are similar to early-stage epiblast cells (E5.5) based on gene expression patterns [51] . These cells readily contribute to chimeras when introduced into preimplantation blastocysts, while other EpiSCs utilizing only the proximal enhancer do not [51] . The chimeras show germline contribution, but they do not produce germline-transmitted offspring [51] . Additionally, two other defined condition systems enable EpiSCs to generate chimeras efficiently after blastocyst injection, but without germline contribution or germline transmission [52, 55] . However, EpiSCs are incorporated efficiently into gastrulation-stage embryos and some differentiate into germline cells in chimeras [41] . These results demonstrate that although the primed EpiSCs under some defined culture conditions can make contact with the host blastocyst cells, the inherent developmental properties of EpiSCs still direct their differentiation toward somatic cell fates.
Isolated epiblasts from E5.5-6.5 are more competent to become PGCLCs in response to BMP4 [25] . EpiLCs share a highly similar cell state to pregastrulating (E5.0-6.0) epiblast cells but are distinct from EpiSCs [6] . These EpiLCs have increased capacity for PGC induction. EpiLCs grow rapidly for the first 2 days and then undergo mass death in EpiSCs culture medium with only 1% knockout serum replacement (KSR) [6] . After EpiLC induction, cells at Day 2 are robustly transformed toward PGCLCs by cytokine induction, but ESCs, Day 1/3 EpiLCs, and EpiSCs are not [6] . P1P14A induction in ES cells results in intense DPPA3 activation, but no PRDM1expression, due to a mutual antagonism between naïve pluripotency and PRDM1 expression [5, 8, 56] Upon stimulation with Activin and FGF2, a 1% concentration of KSR induces ESCs to produce uniform EpiLCs over 3 days. Much higher concentrations of KSR (2%-20%) results in increased maintenance capacity for the ESC-like state, but a lack of KSR results in increased cell death [6] . Similarly, initiated colonies of fewer than 50 human ESCs with only one change of medium after 24 h after seeding and then not for another 4 days generate approximately 25%-30% of cells expressing CXCR4 (a marker of PGCs), a percentage that is higher than with two and four changes of medium [58] . It is likely that the lack of nutrition supports the induction of cells to the PGC-like state that expresses some pluripotent genes but not pluripotency. However, the lack of nutrition is not conducive for the survival of the cells.
SEX-SPECIFIC GERMLINE DEVELOPMENT

Paternal Imprints Are Reinstituted Before Meiosis in Males
When PGCs arrive at the genital ridge, they undergo a second wave of global genome demethylation, including for parental imprints and retrotransponsons. By E13.5, the erasure of most parental imprints is complete [59] . These imprints are reinstituted by methylating their differentially methylated regions (DMRs) according to the gender after the embryo initiates sex determination. In males, the three known paternal imprint loci (H19, Dlk1/Meg3, rasgrf1) resume methylation in prospermatogonia between E14.5 and the newborn stage [60] . In females, the establishment of imprints occurs after birth, during the growth phase of the oocyte [61] .
Nayernia et al. [10] induced spermlike cells from mouse ESCs with retinoic acid. The spermlike cells exhibit the occurrences of acrosome formation, nuclear condensation, and taillike structure formation, and generate offspring by intracytoplasmic sperm injection. Smaller or larger offspring occurs due to abnormal imprint modification and die prematurely. The researchers analyzed DNA methylation of spleen tissues from three offspring. Two offspring with strong hypomethylation of both the H19 imprinting control region and the Snrpn DMR1 display overgrowth, one of which also has a hypermethylated Igf2r DMR2. In contrast, strong hypermethylation of the Snrpn DMR1 displays retarded growth in one offspring. These events indicate that the induced male gametes are not subject to the recovery of paternal imprints due to the absence of essential signaling even though they undergo meiosis.
Ohta et al. [62] examined the time at which male fetal germ cells could differentiate into spermatogonial stem cells (SSCs) in adult recipients. Donor germ cells isolated at E14.5-18.5 differentiate into mature sperm with increased efficiency as embryonic days increased. Donor germ cells isolated at E12.5 show no spermatogenesis; however, the transplanted whole gonad tissue at E12.5 initiates normal spermatogenesis. Furthermore, E11.5 PGCs, when aggregated with E12.5 Sertoli cells for 8 days, show 42% methylation of total CpG sites in the H19 DMRs [63] . These events demonstrate that fetal gonadal somatic cells endow the fetal germ cell with some degree of self-renewal potential when large-scale DNA methylation occurs. Additionally, it can be concluded that lower levels of paternal imprints and retrotransposon silencing affect spermatogenesis. Fetal germ cells as early as E8.5 and even epiblast cells at E6.5 can differentiate into SSCs and initiate normal spermatogenesis after transplantation into 5-to 10-day-old testes, and spermatogenic cells derived from E8.5 and E12.5 PGCs generate normal offspring with the appropriate H19 imprint modification [64] . These events demonstrate that the somatic environment of postnatal testis can regulate differentiation of PGCs toward SSCs. Therefore, male germline induction conditions for establishing the appropriate patent marks can be based on the somatic environment of the postnatal testis. DNMT3L (DNA methyltransferases 3-like), a nuclear protein sharing a similar sequence to DNMT3A and DNMT3B, but no enzymatic activity, plays an essential role in establishing the parental methylation imprints [60, 65, 66] . In the male, DNMT3L interacts with DNMT3A to mediate de novo methylation of imprinted H19 and Dlk1, and interacts with both DNMT3A and DNMT3B to perform Rasgrf1 imprint establishment [60] . DNMT3L maintains high levels of expression in prospermatogonia at E14-18 and then dramatically decreases after birth. In dnmt3l À/À mutant mice, the spermatocytes cannot progress to the full pachytene stage due to asynapsis or abnormal synapsis [67] . Furthermore, the deficiency in retrotransposon silencing in some gene mutants, such as dnmt3l
, and tex19.1
, also show impaired chromosome synapsis in males [68] . DNMT3L is not expressed in spermatocytes but is necessary for normal meiosis, also demonstrating that appropriate methylation patterns should be completed before meiosis.
Resident Environment Defines the Germ Cell Sex
The global gene expression patterns in male and female PGCs are almost identical at E11.5 and become distinct from each other coinciding with sex differentiation at E12.5 [69] . After sex differentiation at around E13.5, male PGCs are arrested in the G0/G1 phase until birth by the degradation of retinoic acid mediated by CYP26B1, whereas female PGCs form primary oocytes and initiate meiosis but arrest at the diplotene stage of prophase I [70] .
Hübner et al. [9] induced floated oocytelike cells from mouse ESCs after as early as 26-day monolayer differentiation culture. The oocytelike cells are enclosed by the fragile zona pellucida (ZP)-like structures and express certain oocytespecific markers (e.g., ZP2 and ZP3). When gonadotropins (e.g., pregnant mare serum gonadotropin and human chorionic gonadotrophin) are added, some oocytelike cells complete the first phase of meiosis and form polar body-like structures. The oocytelike cells even form parthenogenetical blastocystlike structures after approximately 43 days in culture with similar morphology and molecular markers to preimplantation embryos. These researchers also induced oocytelike cells from male ESCs.
Germ cell sex is not determined by sex chromosome constitution of the germline but is dependent on the gonadal environment. XY PGCs develop as oocytes in female chimeric embryos, and XX PGCs develop as prospermatogonia in male chimeric embryos [71] . The XX prospermatogonia undergo paternal imprinting modifications but they die within the first few days after birth [72] , and the XY oocytes show impaired capacity for the second meiotic division [73] . After sex differentiation, testicular cords form in males by the key gene Sry on the Y chromosome. SRY is a pioneer determinant for promoting Sertoli cell differentiation by activating Sox9 expression and is sufficient to promote male gonadal development, as observed with the sex-reversal XY female in sry À/À mutants and the sex-reversal XX male in Sry-transgenic mice [74] [75] [76] . In females, FOXL2 which inhibits SOX9 expression, associates with WNT4 to promote female gonad development, as the loss of Wnt4 and Foxl2 leads to sexreversal XX males [77] .
SIGNALING PATHWAYS REGULATING GERMLINE DEVELOPMENT Kerkis et al. [78] induced both spermlike cells and oocytelike cells from male ESCs by embryoid body formation and retinoic acid induction. The induced spermlike cells are observed on the embryoid body surface, whereas the induced oocytelike cells are localized inside the embryoid bodies, suggesting that the different culture conditions necessary for completion of sex-specific gametogenesis can be obtained from special environments in the embryoid bodies. Isolated male germ cells at E13.5 initiate the meiotic process with added retinoic acid, but isolated male germ cells at E15.5 no longer respond to retinoic acid [79] , demonstrating that the germ cell sex in males is determined by the early somatic environment after sex differentiation.
GERMLINE FROM INDUCED PLURIPOTENT STEM CELLS
Germline-Competent Induced Pluripotent Stem Cells Using the Myc Transgene with a Risk of Tumorigenicity in the Offspring
Induced pluripotent stem cells (iPSCs) are derived from somatic cells and are commonly generated by ectopic expression of Pou5f1, Sox2, Klf4, and Myc (OSKM) and possess most of the characteristics of ESCs. The efficiency of germline transmission of iPSCs in chimeras is closely associated with the involvement of Myc during iPSC reprogramming. Araki et al. [80] 
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Hayashi et al. [6] induced PGCLCs from three mouse iPSC lines. Only PGCLCs from the 20D17 line with steady infection of Myc are similar to those from ESCs, and the PGCLCs contribute to normal spermatogenesis in recipient mice, whereas PGCLCs from iPSC lines without the Myc transgene or with transient expression of Myc show no spermatogenesis or form teratomas. These researchers obtained offspring with spermatozoa from transplanted PGCLCs from the 20D17 iPSC line, but a portion of them suffer from tumors around the neck region and die prematurely.
During reprogramming, Oct4, Sox2, and Klf4 act as the core pluripotency network that is generally believed to be crucial for specifying cell fate change, whereas Myc simply assists OSK to access target sites for amplifying transcriptional outputs [81] . Indeed, few differences are present between the two types of iPSCs (OSKM-and OSK-induced) in terms of analyses of phenotype, molecular biology, cytochemistry, and nonprogrammed differentiation [80, 82, 83] . However, marked differences are evident when the two types of iPSCs are examined for germline contribution. It seems that iPSCs with Myc bear genuine naïve pluripotency, whereas iPSCs without Myc have reduced pluripotency under LIF/BMP4 conditions.
Germline-Competent iPSCs Without the Use of Myc Mediation
Mycl is a mutant of Myc with a shorter amino acid sequence and lower transformation activity than Myc. However, Mycl displays stronger capacity to promote iPSC generation [82] . Significantly, iPSCs produced with Mycl induction contribute to germline transmission in chimeras without tumor formation [82] , suggesting that Mycl is perhaps more suitable for iPSC generation.
Under LIF/BMP4 conditions, ESC self-renewal and pluripotency are dependent on the expression of MYC [84] . Under 2i or 3i (inhibitors of MEK, GSK3B, and FGFR) conditions, the naïve-state ESC self-renewal is maintained with the low levels of MYC [85] . Similarly, under 3i and rat LIF conditions, Hamanaka et al. [86] induced germline-competent rat iPSCs without a Myc transgene. Such rat iPSCs exhibit germline transmission either in rat chimeras or in mouse-rat interspecific chimeras with no tumor development during observations for over 6 mo from progeny.
CONCLUDING REMARKS
Context-dependent regulation of germ cell fate decisions occurs in the entire program of germline development, including PGC specification, meiosis genesis, imprint reestablishment, and sex determination. Several key signaling events have been identified for inducing PGCLCs with transcription profiles and epigenetic profiles that are close to migrating PGCs [6] . Such PGCLCs are competent with a robust capacity for normal gametogenesis in recipient mice. However, the physiological function of PGCLCs is transformed by the postnatal testis in vivo; therefore, the PGCLC identity remains to be identified. Certain induction factors of germline specification seem to limit the proliferation of PGCLCs because BMP4 promotes PGC apoptosis in human fetal ovary and TFAP2c represses the cell cycle of PGCs [19, 87] . The culture conditions for supporting long-term proliferation of PGCs would lay a foundation for the culture of induced PGCLCs. However, such attempts have not been successful because PGCs either undergo apoptosis after several rounds of cell divisions or became pluripotent EGCs [88] . Although the exact signaling pathways regulating germline development at every stage remains relatively unknown, the EpiLC strategy has progressed with regards to obtaining PGCLCs in vitro, and the study of key signaling pathways for directing the sex determination of PGCLCs and subsequent gamete maturation with correct epigenetic modification perhaps can be based on EpiLC-derived PGCLCs (Fig. 3) . Most notably, a number of induced germline cells have given rise to viable offspring [10] , suggesting clinical applications of germline induction in humans.
